Clinical Trials in New York

Showing 15681-15700 of 22,668 trials

Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL

NCT00151320

Primary Objective: To determine the toxicity profile and maximum tolerated dose (MTD) of VELCADE when administered in combination with CHOP + Rituximab to patients with previously untreated diffuse large B cell or mantle cell non-Hodgkin's lymphoma (NHL) Secondary Objectives: To assess the response rate (overall and complete), event-free survival and overall survival with VELCADE and CHOP-R in patients with previously untreated diffuse large B cell or mantle cell lymphoma (phase II component) Treatment: Standard CHOP chemotherapy administered every 21 days (full dose) for six cycles Rituximab administered (375 mg/m2) day 1 of each cycle (with usual premedications) VELCADE is administered prior to rituximab and CHOP on day 1 of each cycle. The dose of VELCADE will be determined by the following dose escalation schedule: Level Dose/Schedule (-2) 0.7 mg/m2 on day 1 of each cycle (-1) 0.7 mg/m2 on days 1 and 8 (0) 0.7 mg/m2 on days 1 and 4 (+1) 1.0 mg/m2 on days 1 and 4 (+2) 1.3 mg/m2 on days 1 and 4

Non-Hodgkin's Lymphoma

Weill Medical College of Cornell University76 participantsStarted Jan 2004

Boston, Massachusetts, United States • Omaha, Nebraska, United States • New York, New York, United States +1 more locations

COMPLETEDNA< 1 mile

Comparative Study of Conventional 1.5 and 3.0T MR Images With Synthetically Reconstructed MR Images

NCT02596854

This study is being conducted for regulatory submission of the GE Healthcare MAGnetic resonance Image Compilation (MAGiC), a point-of-care synthetic MR reconstruction software for GE 1.5T and 3.0T MR scanners.

Clinical Indication for Brain MRI

GE Healthcare117 participantsStarted Nov 2015

Baltimore, Maryland, United States • Grand Rapids, Michigan, United States • New York, New York, United States +3 more locations

Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL

Comparative Study of Conventional 1.5 and 3.0T MR Images With Synthetically Reconstructed MR Images

Find Trials by Condition in New York

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Dronabinol Naltrexone Treatment for Opioid Dependence

Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

Nalrexone Facilitated Discontinuation of Buprenorphine

Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder

Study to Evaluate the Effects of the Cooling Bolero in Women With Common Menopause Symptoms

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

A Phase III Study of Apixaban in Patients With Atrial Fibrillation

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

Phase III Cat-PAD Study

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

Clinical Evaluation of Lapsed Contact Lens Wearers Who Are Re-fit Into Senofilcon A Contact Lenses

Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens

Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies

Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)

B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency